APPEAL WATCH: If You Can’t Patent the Drug, Patent the Dosage
The Supreme Court of Canada (“SCC”) is set to review the patentability of dosage regimens for medical treatments. Last month, the SCC granted leave to appeal [41209] the Federal Court...
Category: Patents
Nova Chemicals Corporation v The Dow Chemical Co: The law of patent remedies takes a step forward
Introduction In Nova Chemicals Corporation v The Dow Chemical Company et al., 2022 SCC 43 (“Nova Chemicals”) the Supreme Court of Canada (“SCC”) clarified the test for determining a proper...
AstraZeneca Canada Inc. v Apotex Inc.: The Supreme Court Overturns the Promise Doctrine
Patents exist to reward inventors and to facilitate the fulsome disclosure of inventions to the public’s benefit. However, prospective patents must meet statutory requirements in order to be approved. As...
Teva v Pfizer: How Viagra Allowed the SCC to Stiffen Patent Disclosure Requirements
Canadian patent law has undergone a number of significant developments throughout the past year, with numerous issues capturing the attention of the Supreme Court of Canada (“SCC”). In particular, the...
